These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 11284646

  • 1. Feto-maternal alloimmune thrombocytopenia: a literature review and statistical analysis.
    Spencer JA, Burrows RF.
    Aust N Z J Obstet Gynaecol; 2001 Feb; 41(1):45-55. PubMed ID: 11284646
    [Abstract] [Full Text] [Related]

  • 2. Anti-HPA-9bw (Maxa) fetomaternal alloimmunization, a clinically severe neonatal thrombocytopenia: difficulties in diagnosis and therapy and report on eight families.
    Kaplan C, Porcelijn L, Vanlieferinghen P, Julien E, Bianchi F, Martageix C, Bertrand G, Jallu V.
    Transfusion; 2005 Nov; 45(11):1799-803. PubMed ID: 16271107
    [Abstract] [Full Text] [Related]

  • 3. Antenatal management of fetomaternal alloimmune thrombocytopenia--report of 15 affected pregnancies.
    Murphy MF, Waters AH, Doughty HA, Hambley H, Mibashan RS, Nicolaides K, Rodeck CH.
    Transfus Med; 1994 Dec; 4(4):281-92. PubMed ID: 7889140
    [Abstract] [Full Text] [Related]

  • 4. Antenatal care in pregnancies at risk of alloimmune thrombocytopenia: report of 19 cases in 16 families.
    Kanhai HH, Porcelijn L, van Zoeren D, Klumper F, Viëtor H, Meerman RH, Brand A.
    Eur J Obstet Gynecol Reprod Biol; 1996 Sep; 68(1-2):67-73. PubMed ID: 8886684
    [Abstract] [Full Text] [Related]

  • 5. Feto-maternal alloimmune thrombocytopenia: antenatal therapy with IvIgG and steroids--more questions than answers. European Working Group on FMAIT.
    Kaplan C, Murphy MF, Kroll H, Waters AH.
    Br J Haematol; 1998 Jan; 100(1):62-5. PubMed ID: 9450792
    [Abstract] [Full Text] [Related]

  • 6. Neonatal alloimmune thrombocytopenia: antenatal management.
    Silver RM, Porter TF, Branch DW, Esplin MS, Scott JR.
    Am J Obstet Gynecol; 2000 May; 182(5):1233-8. PubMed ID: 10819864
    [Abstract] [Full Text] [Related]

  • 7. Antenatal management of severe feto-maternal alloimmune thrombocytopenia: HLA incompatibility may affect responses to fetal platelet transfusions.
    Murphy MF, Metcalfe P, Waters AH, Ord J, Hambley H, Nicolaides K.
    Blood; 1993 Apr 15; 81(8):2174-9. PubMed ID: 8471776
    [Abstract] [Full Text] [Related]

  • 8. Antenatal interventions for fetomaternal alloimmune thrombocytopenia.
    Rayment R, Brunskill SJ, Stanworth S, Soothill PW, Roberts DJ, Murphy MF.
    Cochrane Database Syst Rev; 2005 Jan 25; (1):CD004226. PubMed ID: 15674934
    [Abstract] [Full Text] [Related]

  • 9. Prenatal treatment of severe fetomaternal alloimmune thrombocytopenia.
    Sainio S, Teramo K, Kekomäki R.
    Transfus Med; 1999 Dec 25; 9(4):321-30. PubMed ID: 10583886
    [Abstract] [Full Text] [Related]

  • 10. European collaborative study of the antenatal management of feto-maternal alloimmune thrombocytopenia.
    Birchall JE, Murphy MF, Kaplan C, Kroll H, European Fetomaternal Alloimmune Thrombocytopenia Study Group.
    Br J Haematol; 2003 Jul 25; 122(2):275-88. PubMed ID: 12846898
    [Abstract] [Full Text] [Related]

  • 11. Management and outcome of 200 cases of fetomaternal alloimmune thrombocytopenia.
    Ghevaert C, Campbell K, Walton J, Smith GA, Allen D, Williamson LM, Ouwehand WH, Ranasinghe E.
    Transfusion; 2007 May 25; 47(5):901-10. PubMed ID: 17465957
    [Abstract] [Full Text] [Related]

  • 12. [Prenatal management of fetuses with alloimmune thrombocytopenia].
    Kroll H, Kiefel V, Giers G, Kaplan C, Murphy M, Waters A, Mueller-Eckhardt C.
    Beitr Infusionsther Transfusionsmed; 1996 May 25; 33():150-5. PubMed ID: 8974688
    [Abstract] [Full Text] [Related]

  • 13. The management of alloimmune neonatal thrombocytopenia.
    Blanchette VS, Johnson J, Rand M.
    Baillieres Best Pract Res Clin Haematol; 2000 Sep 25; 13(3):365-90. PubMed ID: 11030040
    [Abstract] [Full Text] [Related]

  • 14. Effect of IVIgG treatment on fetal platelet count, HPA-1a titre and clinical outcome in a case of feto-maternal alloimmune thrombocytopenia.
    Lucas GF, Hamon M, Carroll S, Soothill P.
    BJOG; 2002 Oct 25; 109(10):1195-8. PubMed ID: 12387480
    [No Abstract] [Full Text] [Related]

  • 15. HPA-1a antibody potency and bioactivity do not predict severity of fetomaternal alloimmune thrombocytopenia.
    Ghevaert C, Campbell K, Stafford P, Metcalfe P, Casbard A, Smith GA, Allen D, Ranasinghe E, Williamson LM, Ouwehand WH.
    Transfusion; 2007 Jul 25; 47(7):1296-305. PubMed ID: 17581167
    [Abstract] [Full Text] [Related]

  • 16. Usefulness of maternal anti-HPA-1a antibody quantitation in predicting severity of foetomaternal alloimmune thrombocytopenia.
    Sainio S, Javela K, Tuimala J, Koskinen S.
    Transfus Med; 2013 Apr 25; 23(2):114-20. PubMed ID: 23448161
    [Abstract] [Full Text] [Related]

  • 17. [Intravenous human immunoglobulin treatment for neonatal alloimmune thrombocytopenia due to anti-HPA-5b with severe previous history].
    Moncharmont P, Vignal M, Merieux Y, Rigal D.
    Arch Pediatr; 2007 Sep 25; 14(9):1094-6. PubMed ID: 17590318
    [Abstract] [Full Text] [Related]

  • 18. Prenatal management of fetal alloimmune thrombocytopenia.
    Vox Sang; 1993 Sep 25; 65(3):180-9. PubMed ID: 8249359
    [No Abstract] [Full Text] [Related]

  • 19. The management of feto-maternal alloimmune thrombocytopenia: report of three cases.
    Paternoster DM, Cester M, Memmo A, Scandellari R, Fabris F, Girolami A.
    J Matern Fetal Neonatal Med; 2006 Aug 25; 19(8):517-20. PubMed ID: 16966118
    [Abstract] [Full Text] [Related]

  • 20. Feto-maternal alloimmune thrombocytopenia due to HPA-5b incompatibility: a case report.
    Herrero RJ, Chitrit Y, Caubel P, Lusina D.
    Eur J Obstet Gynecol Reprod Biol; 2003 Oct 10; 110(2):240-1. PubMed ID: 12969593
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.